Adma Biologics (ADMA) Earnings
|
Expand Research on ADMA
| Next EPS Date | 8/12/26 | EPS Growth Rate | +57.1% |
|---|---|---|---|
| Average EPS % Beat Rate | -1.6% | Revenue Growth Rate | +10.2% |
| Average % Move 1-Wk after EPS | -2.8% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 8/12/26 |
Q226 | N/A | $0.22 | N/A | N/A | $134.42M | = | N/A | N/A | ||
| 5/6/26 | Q126 | $0.19 | $0.20 | -$0.01 | $114.5M | $142.74M | = | ![]() | ![]() | Details | |
| 2/25/26 | Q425 | $0.20 | $0.19 | +$0.01 | $139.16M | $139.85M | = | ![]() | ![]() | Details | |
| 11/5/25 | Q325 | $0.15 | $0.15 | $0.00 | $134.2M | $131.19M | = | ![]() | ![]() | Details | |
| 8/6/25 | Q225 | $0.14 | $0.15 | -$0.01 | $121.98M | $124.13M | = | ![]() | ![]() | Details | |
| 5/7/25 |
Q125 | N/A | $0.15 | N/A | N/A | $112.97M | = | N/A | N/A | ||
| 3/3/25 |
Q424 | $0.46 | $0.15 | +$0.31 | $117.5M | $113.4M | = | ![]() | ![]() | Details | |
| 11/7/24 |
Q324 | $0.15 | $0.13 | +$0.02 | $119.8M | $105.96M | = | ![]() | ![]() | Details |


